Literature DB >> 807057

[Significance of the antibacterial agent assay of urine for bacteriological diagnosis and control of chemotherapy of urinary tract infections (author's transl)].

R Ansorg, H Zappel, R Thomssen.   

Abstract

The disc agar-diffusion-test using Bacillus subtilis ATCC 6051 as test organism is a simple and rapid method for routine testing of antibacterial agents in urine specimens. The test records urine levels which are expected under medium dosage, and in many cases even lower concentrations of renal excreted antibiotics. Out of 5655 analysed urine samples 22% contain antibacterial substances. In urine specimens over which information was volunteered that either no chemotherapy had been administered or that more than a three day's interval free of therapy existed, inhibitory substances are found in 8% and 27% respectively. Urine specimens which are supposedly collected from patients under current chemotherapy do not show therapeutic relevant antibiotic levels in 26%. Between urine specimens with and without antibacterial activity there is no significant difference in the incidence of viable counts of 10-4-10-5/ml and 10-5/ml. From urine samples with antibacterial content increases in the numbers of multiple resistant strains of E. coli, Proteus spp., Pseudom. aerug. and Enterobacter spp. together with high numbers of Candida spp. are observed.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 807057

Source DB:  PubMed          Journal:  Zentralbl Bakteriol Orig A        ISSN: 0300-9688


  2 in total

1.  Antibiotic screening of urine culture as a tool for interal quality audit.

Authors:  Sreenivasan Srirangaraj; Arunava Kali; Mv Pravin Charles
Journal:  Australas Med J       Date:  2014-02-28

2.  Urine antibiotic activity in patients presenting to hospitals in Laos: implications for worsening antibiotic resistance.

Authors:  Manisone Khennavong; Viengmon Davone; Manivanh Vongsouvath; Rattanaphone Phetsouvanh; Joy Silisouk; Olay Rattana; Mayfong Mayxay; Josée Castonguay-Vanier; Catrin E Moore; Michel Strobel; Paul N Newton
Journal:  Am J Trop Med Hyg       Date:  2011-08       Impact factor: 2.345

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.